News

AvantGen, Inc., a San Diego-based biotechnology company with an array of technology platforms for antibody discovery and optimization, and novel NK and T cell engager generation, announced licensing of a panel of its anti-SARS-CoV-2 antibody clones to IGM Biosciences...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Kuehne+Nagel, a world-leading logistics company, announced that they have agreed an international supply chain arrangement to provide distribution and storage of the Covid-19 Vaccine Moderna. This...

Dr Reddy’s Laboratories (DRL) on Monday announced the start of its phase 3 clinical trial of Russia's Sputnik V Covid-19 vaccine after receiving clearance from the independent Data and Safety Monitoring Board (DSMB). DSMB’s clearance is based on the safety...

Bharat Biotech inked a purchase agreement with the Government of India on January 11 to provide 55 lakh doses of COVID-19 vaccine Covaxin at Rs 295 per dose. The Indian pharma firm will be providing its coronavirus vaccine directly to...

The government has placed orders in advanced commitments for over 6 crore doses of Covid-19 vaccine from Serum Institute of India (SII) and Bharat Biotech for inoculating 3 crore healthcare and frontline workers in the first phase of the...

Roche announced that the EC has approved Xofluza (baloxavir marboxil) for the treatment of uncomplicated influenza in patients aged 12 years and above. In addition, the EC has approved Xofluza for post-exposure prophylaxis of influenza in individuals aged 12...

Dr. Reddy’s Laboratories Ltd., along with its subsidiaries together referred to as “Dr. Reddy’s”) announced the launch of Febuxostat Tablets, a therapeutic equivalent generic version of Uloric (Febuxostat) Tablets approved by the U.S. FDA. The Uloric brand and generic had...